IMARC Group has published a market research report titled “United States Biotechnology Market Report by Product Type (Instruments, Reagents, Software and Services), Technology (Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-Based Assays, Fermentation, PCR Technology, Chromatography, and Others), Application (Healthcare, Food and Agriculture, Natural Resources and Environment, Industrial Processing, Bioinformatics, and Others), and Region 2024-2032“, United States biotechnology market size is projected to exhibit a growth rate (CAGR) of 9.50% during 2024-2032.
The advancements in scientific research as well as innovation in technology are the factors responsible for the growth of the United States biotechnology market. Additionally, the demand for biotechnology is escalating owing to the surge in personalized medicine, where treatments are tailored to individual genetic profiles. Advances in genomic sequencing and CRISPR gene-editing technology are enabling breakthroughs in disease prevention and treatment, particularly in oncology, rare genetic disorders, and infectious diseases. Moreover, the COVID-19 pandemic has bolstered the adoption of biotechnological solutions, underscoring the importance of biotechnology in addressing global health challenges and spurring increased funding and interest in the sector.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-biotechnology-market/requestsample
United States Biotechnology Market Trends and Drivers:
In addition to healthcare, the agricultural biotechnology segment is also witnessing significant growth in the United States market. Besides this, the demand for sustainable practices as well as the need to enhance crop productivity to feed a growing population are driving the adoption of genetically modified organisms and biopesticides. Innovations in biotechnology are also leading to the development of crops that are more resistant to pests, diseases, and environmental stresses, thereby improving agricultural productivity and sustainability. Furthermore, support and regulatory frameworks by government authorities are playing a major role in fostering the biotechnology market, with policies aimed at encouraging innovation, ensuring safety, and facilitating the commercialization of biotechnological products. In line with this, partnerships between biotech companies, academic institutions, and government authorities are accelerating the translation of research into practical applications, which is anticipated to drive the United States biotechnology market over the forecasted period.
Report Segmentation:
The report has segmented the market into the following categories:
Product Type Insights:
- Instruments
- Reagents
- Software and Services
Technology Insights:
- Nanobiotechnology
- Tissue Engineering and Regeneration
- DNA Sequencing
- Cell-Based Assays
- Fermentation
- PCR Technology
- Chromatography
- Others
Application Insights:
- Healthcare
- Food and Agriculture
- Natural Resources and Environment
- Industrial Processing
- Bioinformatics
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163